Adding narrowband ultraviolet B (UVB) phototherapy to oral treatment with ritlecitinib (Litfulo) enhanced repigmentation in patients with nonsegmental vitiligo compared with the drug alone, ...

Similar reductions were seen in body vitiligo severity. Narrow-band ultraviolet B phototherapy improved the efficacy of ritlecitinib for the treatment of patients with nonsegmental vitiligo ...

Phototherapy with topical antioxidants is the most effective combination for vitiligo, followed by corticosteroids and calcineurin inhibitors.

Adding nbUVB phototherapy to oral ritlecitinib improves facial and total body repigmentation in patients with nonsegmental ...

Narrow-band ultraviolet B (NB-UVB) light therapy at 311 nm is a common treatment for vitiligo. Doctors prefer it over PUVA because it is safer and more effective. Red light therapy also helps by ...

First results of SCENESSE® study expected in 2H 2026Executive summary Recruitment target of 200 vitiligo patients ...

The dermatologist may order treatments such as topical steroids, phototherapy (PUVA or narrow-band UVB), nitrogen mustard, and BCNU (carmustine). A patient may be referred to a radiation ...

Patients receive treatment with either SCENESSE® every three weeks alongside adjuvant narrowband ultraviolet B (NB-UVB) phototherapy administered twice weekly, or NB-UVB monotherapy twice weekly ...

Adding twice-weekly narrowband UVB phototherapy to oral ritlecitinib may enhance response to treatment of nonsegmental vitiligo. Dual treatment was well-tolerated with no new safety signals in ...